Shares of Altimmune ALT fell 27.04% during market hours on Sep 14, even after the company announced positive top-line results from its 12-week phase I study. The study evaluated pemvidutide in ...
Apple customers are generally a shockingly loyal bunch. The company's high repeat customer rate can be attributed to a combination of factors that concern iPhones themselves as well as Apple's ...
As automakers continue to introduce more EVs, public charging is proving unreliable, according to the latest J.D. Power Electric Vehicle Experience Public Charging study. The study found that 20% of ...
UNESCO warned that the “low prevalence of fact-checking highlights influencers’ vulnerability to misinformation, which can have far-reaching consequences for public trust and discourse.” According to ...
Biohaven Pharmaceuticals BHVN recently announced that the phase II/III HEALY ALS platform study evaluating verdiperstat for treating Amyotrophic Lateral Sclerosis (ALS) failed. ALS is a progressive, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback